D

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

By Dr. Sharmila Ghimire FEATURING Dr. Sharmila Ghimire
0 views
September 13, 2023
Journal Club Presentation
Comments 0
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Recommended

AUTOPLAY
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
34:49
Scripps Health

Medications for Weight Loss: The New Satiety Hormones

Feat. K. Fujioka
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

08:46
Robert Busch

FLOW Trial Results: GLPs, the Kidneys, and Even More to Come!!

12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
26:49
Diana Isaacs

Tirzepatide Updates

26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
20:24
Diana Isaacs

Tirzepatide for Type 2 Diabetes

44:41
Norman Lepor

Obesity: New Understanding and Treatments

06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

05:08
Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

09:44
Susan Brian

Mounjaro Update 2024

36:34
Scripps Health

GLP-1 Hysteria

Feat. S. Harris
23:35
Canadian Collaborative Research Network

Is Obesity Management the Next Frontier?

Feat. A. Michael Lincoff
11:07
Susan Brian

Wegovy 2024 Updates

38:07
Rodolfo Galindo

Diabesity: The True Pandemic of the XXI Century

49:21
McMaster University Department of Medicine

Semaglutide: Where Are We Now and Where Are We Going?

Feat. S. Boushahri, D. Lazzam, K. MacEachern